top of page
Terumo to acquire OrganOx in ~$1.5B deal, entering organ-transplant technology
TOKYO — Aug. 25, 2025.  Terumo (TSE: 4543) has signed a definitive agreement to acquire UK-based OrganOx, a pioneer in normothermic...
Orsco Lifesciences AG
Aug 251 min read
OrganOx Closes Second Private Placement, Raising $160M for NMP Platform Expansion
Oxford, UK & Madison, NJ — May 8, 2025.  OrganOx Ltd. has completed a second closing of its private placement, securing investments from...
Orsco Lifesciences AG
May 81 min read
Phagenesis raises $42M to accelerate U.S. rollout of dysphagia therapy
Manchester, UK — Mar 4, 2024.  Phagenesis closed a $42 million Series D  to scale U.S. commercialization of Phagenyx® , its...
Orsco Lifesciences AG
Mar 41 min read
OrganOx Raises $142M Financing Led by HealthQuest Capital
Oxford, UK & Madison, NJ — Feb 24, 2025.  OrganOx Ltd. has completed an oversubscribed $142 million equity financing  (primary and...
Orsco Lifesciences AG
Feb 242 min read
OrganOx and eGenesis Forge Exclusive Clinical Co-Development Agreement to Advance Porcine-Supported Liver Rescue
Oxford, UK & Cambridge, MA — November 12, 2024.  OrganOx and eGenesis have entered into an exclusive clinical co-development agreement...
Orsco Lifesciences AG
Nov 12, 20241 min read
Neo Medical raises $68M to scale AI-enhanced spine surgery platform
Lausanne, Switzerland — Sept 17, 2024.  Neo Medical closed a $68m Series B  (incl. conversion of shareholder loans) led by Gyrus Capital...
Orsco Lifesciences AG
Sep 17, 20241 min read
bottom of page